Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

GLOBAL MARKETS-Stocks falter, dollar slips on potential U.S.-China trade delay

Published 30/10/2019, 08:06 am
Updated 30/10/2019, 08:07 am
© Reuters.  GLOBAL MARKETS-Stocks falter, dollar slips on potential U.S.-China trade delay

* S&P 500 hits intraday record, but closes lower

* Poor earnings cloud European equities

* Dollar slips on potential delay in U.S.-China trade deal

* Graphic: World FX rates in 2019 http://tmsnrt.rs/2egbfVh

By Herbert Lash

NEW YORK, Oct 29 (Reuters) - Global stocks faltered on Tuesday as strong earnings from U.S. drugmakers Merck and Pfizer and expectations the Federal Reserve will cut rates was offset by a potential delay in a U.S.-China trade deal, which clouded sentiment and weakened the dollar.

European shares fell as companies headed toward their worst quarterly earnings in more than three years, according to the latest estimates by Refinitiv, underscoring concerns about the deteriorating health of Europe Inc.

The U.S. S&P 500 index eked out a fresh record intraday high, led by Merck and Pfizer, though a disappointing profit report from Google parent Alphabet (NASDAQ:GOOGL) kept the technology-rich Nasdaq in the red.

The benchmark index had breached its all-time high set in July on Monday, spurred by hopes of a U.S.-China trade deal and the likelihood of further stimulus from the U.S. central bank on Wednesday when it concludes a two-day meeting of policy-makers.

The steepening of the two- and 10-year yield curve suggests a budding risk-on sentiment among investors, now that some form of a U.S.-China trade agreement is likely, said Yousef Abbasi, global market strategist at INTL FCStone Financial in New York.

The spread in the yield curve US2US10=TWEB has gained about 20 basis points since leaving negative territory, a recession indicator, in early September.

However, a U.S. administration official said on Tuesday that an interim trade agreement might not be completed in time for signing in Chile next month as expected, while adding that did not mean the accord is falling apart. .SPLRCT shares, a sector of the S&P 500 that has been closely tied to trade progress, fell 0.92%.

Drugmakers Merck & Co Inc MRK.N and Pfizer Inc (NYSE:PFE) PFE.N rose after reporting upbeat third-quarter results, gaining 3.5% and 2.5%, respectively. The healthcare sector .SPXHC , which has been the second-worst performer among the 11 major S&P 500 sectors this year, rose 1.16% as the session's best performer. rotation into value stocks that investors have posited for months seems be taking hold, Abbasi said, pointing to recent gains in the SPDR S&P Regional Banking ETF KRE as evidence. The ETF has traded below 56 since May and could be set for further upside after a recent rally from below 50, he said.

"We're seeing some of those high-flying tech names struggle," Abbasi said. "We're getting that risk-on move from sectors that have been ignored all year, the sectors that haven't been loved."

Apple AAPL.O and Microsoft MSFT.O fell, as did Amazon.com AMZN.O .

MSCI's gauge of stocks across the globe .MIWD00000PUS gained 0.05%, while the pan-European STOXX 600 index .STOXX lost 0.16%. MSCI's emerging markets index .MSCIEF rose 0.07%.

On Wall Street, the Dow Jones Industrial Average .DJI fell 19.26 points, or 0.07%, to 27,071.46. The S&P 500 .SPX lost 2.53 points, or 0.08%, to 3,036.89 and the Nasdaq Composite .IXIC dropped 49.14 points, or 0.59%, to 8,276.85.

Oil pared losses amid expectations that U.S. refined product stockpiles declined last week.

Brent crude LCOc1 rose 2 cents to settle at $61.59 a barrel, while U.S. West Texas Intermediate CLc1 crude settled down 27 cents to $55.54.

Britain's FTSE 100 .FTSE fell 0.34% as uncertainty over a looming general election compounded a 4.0% drop in shares of BP BP.L after the oil major posted a sharp drop in third quarter profit. losses in Europe followed a mixed performance in Asia, where Japan's Nikkei .N225 rose 0.4% to reach levels last seen a year ago. Shanghai blue chips .CSI300 dithered either side of flat.

Benchmark 10-year U.S. notes US10YT=RR rose 4/32 in price to yield 1.8367%.

The dollar index .DXY fell 0.09%, with the euro EUR= up 0.13% to $1.1112. The Japanese yen JPY= strengthened 0.10% versus the greenback at 108.86 per dollar.

https://tmsnrt.rs/2zpUAr4 Asia-Pacific valuations

https://tmsnrt.rs/2Dr2BQA Trump: 'ahead of schedule' on China trade deal

U.S. may extend tariff suspensions on $34 billion in Chinese goods

Microsoft beats Amazon for Pentagon's $10 bln cloud computing contract

Google's search for sales in cloud, hardware clip Alphabet profit

EU agrees Brexit delay as British parliament blocks December election

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.